Our research group has previously demonstrated the multifaceted roles of salt-inducible kinase 2 (SIK2), which is a member of the AMP-activated protein kinase (AMPK)-related kinase family [51, 52], in the regulation of various biological and molecular functions in ovarian cancer, including cell survival, proliferation, and sensitivity to paclitaxel [53]. This evidence concerns the gene SIK2 and ovarian carcinoma.